Javle M - Search Results

1

Impact of hypofractionated and standard fractionated chemoradiation before pancreatoduodenectomy for pancreatic ductal adenocarcinoma.

Cloyd JM, Crane CH, Koay EJ, Das P, Krishnan S, Prakash L, Snyder RA, Varadhachary GR, Wolff RA, Javle M, Shroff RT, Fogelman D, Overman M, Wang H, Maitra A, Lee JE, Fleming JB, Katz MH. Cloyd JM, et al. Among authors: javle m. Cancer. 2016 Sep 1;122(17):2671-9. doi: 10.1002/cncr.30117. Epub 2016 May 31. Cancer. 2016. PMID: 27243381 Free PMC article.

2

Risk factors associated with earlier age of onset in familial pancreatic carcinoma.

James TA, Sheldon DG, Rajput A, Kuvshinoff BW, Javle MM, Nava HR, Smith JL, Gibbs JF. James TA, et al. Among authors: javle mm. Cancer. 2004 Dec 15;101(12):2722-6. doi: 10.1002/cncr.20700. Cancer. 2004. PMID: 15534880 Free article.

3

Concurrent oxaliplatin, 5-fluorouracil, and radiotherapy in the treatment of locally advanced esophageal carcinoma.

O'Connor BM, Chadha MK, Pande A, Lombardo JC, Nwogu CE, Nava HR, Yang G, Javle MM. O'Connor BM, et al. Among authors: javle mm. Cancer J. 2007 Mar-Apr;13(2):119-24. doi: 10.1097/PPO.0b013e318046ee1a. Cancer J. 2007. PMID: 17476140

4

Capecitabine, oxaliplatin and radiotherapy: a phase IB neoadjuvant study for esophageal cancer with gene expression analysis.

Javle MM, Yang G, Nwogu CE, Wilding GE, O'Malley L, Vinjamaram S, Schiff MD, Nava HR, LeVea C, Clark KR, Prey JD, Smith PF, Pendyala L. Javle MM, et al. Cancer Invest. 2009 Feb;27(2):193-200. doi: 10.1080/07357900802172093. Cancer Invest. 2009. PMID: 19235592 Clinical Trial.

5

Updates in Gastrointestinal Oncology - insights from the 2008 44th annual meeting of the American Society of Clinical Oncology.

Javle M, Hsueh CT. Javle M, et al. J Hematol Oncol. 2009 Feb 23;2:9. doi: 10.1186/1756-8722-2-9. J Hematol Oncol. 2009. PMID: 19236713 Free PMC article.

6

Reirradiation to the abdomen for gastrointestinal malignancies.

Haque W, Crane CH, Krishnan S, Delclos ME, Javle M, Garrett CR, Wolff RA, Das P. Haque W, et al. Among authors: javle m. Radiat Oncol. 2009 Nov 18;4:55. doi: 10.1186/1748-717X-4-55. Radiat Oncol. 2009. PMID: 19922641 Free PMC article.

7

Single nucleotide polymorphisms of gemcitabine metabolic genes and pancreatic cancer survival and drug toxicity.

Okazaki T, Javle M, Tanaka M, Abbruzzese JL, Li D. Okazaki T, et al. Among authors: javle m. Clin Cancer Res. 2010 Jan 1;16(1):320-9. doi: 10.1158/1078-0432.CCR-09-1555. Epub 2009 Dec 22. Clin Cancer Res. 2010. PMID: 20028759 Free PMC article.

8

A phase II study of isoflavones, erlotinib, and gemcitabine in advanced pancreatic cancer.

El-Rayes BF, Philip PA, Sarkar FH, Shields AF, Ferris AM, Hess K, Kaseb AO, Javle MM, Varadhachary GR, Wolff RA, Abbruzzese JL. El-Rayes BF, et al. Among authors: javle mm. Invest New Drugs. 2011 Aug;29(4):694-9. doi: 10.1007/s10637-010-9386-6. Epub 2010 Jan 27. Invest New Drugs. 2011. PMID: 20107864 Clinical Trial.

9

Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma.

Hassan MM, Curley SA, Li D, Kaseb A, Davila M, Abdalla EK, Javle M, Moghazy DM, Lozano RD, Abbruzzese JL, Vauthey JN. Hassan MM, et al. Among authors: javle m. Cancer. 2010 Apr 15;116(8):1938-46. doi: 10.1002/cncr.24982. Cancer. 2010. PMID: 20166205 Free PMC article.

10

Insulin-like growth factor axis gene polymorphisms and clinical outcomes in pancreatic cancer.

Dong X, Javle M, Hess KR, Shroff R, Abbruzzese JL, Li D. Dong X, et al. Among authors: javle m. Gastroenterology. 2010 Aug;139(2):464-73, 473.e1-3. doi: 10.1053/j.gastro.2010.04.042. Epub 2010 Apr 21. Gastroenterology. 2010. PMID: 20416304 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

272 results

Search Page